Where Will Morgan Stanley Stock Be in 10 Years?
Morgan Stanley (NYSE:MS) share price has been on a tear,…
Sell
48
ACHC Quote, Financials, Valuation and Earnings
Last price:
$44.27
Seasonality move
:
5.36%
Day range:
$43.54 - $44.46
52-week range:
$36.50 - $87.77
Dividend yield:
0%
P/E ratio:
14.51x
P/S ratio:
1.30x
P/B ratio:
1.36x
Volume:
1.6M
Avg. volume:
1.9M
1-year change:
-48.36%
Market cap:
$4.1B
Revenue:
$2.9B
EPS (TTM):
$3.05
Analysts' Opinion
-
Consensus RatingAcadia Healthcare has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $61.38, Acadia Healthcare has an estimated upside of 38.35% from its current price of $44.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $43.00 representing 2.87% downside risk from its current price of $44.37.
Fair Value
-
According to the consensus of 11 analysts, Acadia Healthcare has 38.35% upside to fair value with a price target of $61.38 per share.
ACHC vs. S&P 500
-
Over the past 5 trading days, Acadia Healthcare has underperformed the S&P 500 by -3.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Acadia Healthcare does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Acadia Healthcare has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Acadia Healthcare reported revenues of $815.6M.
Earnings Growth
-
Acadia Healthcare has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Acadia Healthcare reported earnings per share of $0.74.
Enterprise value:
6B
EV / Invested capital:
--
Price / LTM sales:
1.30x
EV / EBIT:
12.29x
EV / Revenue:
1.93x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.15x
Price / Operating cash flow:
81.81x
Enterprise value / EBITDA:
9.48x
Gross Profit (TTM):
$3B
Return On Assets:
5.05%
Net Income Margin (TTM):
8.99%
Return On Equity:
9.43%
Return On Invested Capital:
6.05%
Operating Margin:
18.05%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.5B | $2.9B | $3.1B | $750.3M | $815.6M | |
| Gross Profit | $2.4B | $2.8B | $3B | $723.2M | $786M | |
| Operating Income | $470M | $498.9M | $545.8M | $138.8M | $147.2M | |
| EBITDA | $564.1M | $190.9M | $636M | -$233.3M | $166.1M | |
| Diluted EPS | $3.10 | -$0.21 | $3.05 | -$2.39 | $0.74 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $756.4M | $567.2M | $521.7M | $703.5M | $652.1M | |
| Total Assets | $7.1B | $4.6B | $4.9B | $5.3B | $5.9B | |
| Current Liabilities | $601.3M | $403.3M | $401M | $864.9M | $609.5M | |
| Total Liabilities | $4.5B | $2.2B | $2.1B | $2.5B | $2.7B | |
| Total Equity | $2.6B | $2.4B | $2.8B | $2.8B | $3.1B | |
| Total Debt | $3.1B | $1.4B | $1.4B | $1.4B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $364.9M | $459.6M | $129.3M | $137.9M | $163.1M | |
| Cash From Investing | -$443.8M | -$379.1M | -$643.3M | -$129.4M | -$193.1M | |
| Cash From Financing | -$24M | -$74.3M | $496.6M | -$21.1M | $34.9M | |
| Free Cash Flow | $67.9M | $86.8M | -$496.3M | $9.8M | -$27.1M | |
ACHC
Sector
Market Cap
$4.1B
$45.8M
Price % of 52-Week High
50.44%
47.1%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
-48.36%
-32.38%
Beta (5-Year)
1.292
0.746
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$44.12
200-day SMA
Sell
Level
$61.12
Bollinger Bands (100)
Sell
Level
37.63 - 67.79
Chaikin Money Flow
Buy
Level
2.2M
20-day SMA
Buy
Level
$41.70
Relative Strength Index (RSI14)
Buy
Level
58.90
ADX Line
Buy
Level
38.38
Williams %R
Neutral
Level
-27.3185
50-day SMA
Buy
Level
$40.82
MACD (12, 26)
Buy
Level
0.82
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Sell
Level
-53.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2741)
Buy
CA Score
(Annual)
Level (-0.0067)
Buy
Beneish M-Score
(Annual)
Level (-2.8795)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-7.2128)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Stock Forecast FAQ
In the current month, ACHC has received 9 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ACHC average analyst price target in the past 3 months is $61.38.
-
Where Will Acadia Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that Acadia Healthcare share price will rise to $61.38 per share over the next 12 months.
-
What Do Analysts Say About Acadia Healthcare?
Analysts are divided on their view about Acadia Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Acadia Healthcare is a Sell and believe this share price will drop from its current level to $43.00.
-
What Is Acadia Healthcare's Price Target?
The price target for Acadia Healthcare over the next 1-year time period is forecast to be $61.38 according to 11 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ACHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Acadia Healthcare is a Buy. 9 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ACHC?
You can purchase shares of Acadia Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Acadia Healthcare shares.
-
What Is The Acadia Healthcare Share Price Today?
Acadia Healthcare was last trading at $44.27 per share. This represents the most recent stock quote for Acadia Healthcare. Yesterday, Acadia Healthcare closed at $44.37 per share.
-
How To Buy Acadia Healthcare Stock Online?
In order to purchase Acadia Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 123x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Alerts
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is up 9.81% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 1.13% over the past day.
Buy
51
GH alert for Jan 22
Guardant Health [GH] is up 4.5% over the past day.
